Growth Metrics

Cytokinetics (CYTK) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Cytokinetics (CYTK) over the last 13 years, with Q3 2024 value amounting to 0.07.

  • Cytokinetics' Debt Ratio fell 1062.18% to 0.07 in Q3 2024 from the same period last year, while for Sep 2024 it was 0.07, marking a year-over-year decrease of 1062.18%. This contributed to the annual value of 0.08 for FY2023, which is 3013.01% up from last year.
  • Per Cytokinetics' latest filing, its Debt Ratio stood at 0.07 for Q3 2024, which was down 1062.18% from 0.07 recorded in Q2 2024.
  • Over the past 5 years, Cytokinetics' Debt Ratio peaked at 0.2 during Q2 2020, and registered a low of 0.06 during Q4 2021.
  • Moreover, its 5-year median value for Debt Ratio was 0.08 (2021), whereas its average is 0.09.
  • Per our database at Business Quant, Cytokinetics' Debt Ratio tumbled by 5945.24% in 2020 and then skyrocketed by 3920.04% in 2023.
  • Cytokinetics' Debt Ratio (Quarter) stood at 0.09 in 2020, then plummeted by 34.96% to 0.06 in 2021, then rose by 13.36% to 0.06 in 2022, then surged by 30.13% to 0.08 in 2023, then dropped by 11.53% to 0.07 in 2024.
  • Its Debt Ratio was 0.07 in Q3 2024, compared to 0.07 in Q2 2024 and 0.08 in Q1 2024.